Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Legal Entity [Axis] ILiAD Biotechnologies, LLC [Member] Product and Service [Axis] Litigation Settlements [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Plan Name [Axis] Stock Incentive Plan 2022 [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Investment, Issuer Name [Axis] Cost Basis [Member] Gross Unrealized Gains [Member] Gross Unrealized Losses [Member] Concentration Risk Benchmark [Axis] Fair Value [Member] Title and Position [Axis] Chief Executive Officer [Member] Prior Employment Agreement [Member] Sale of Stock [Axis] Private Placement [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Series A 1 Preferred Stock [Member] Board Of Directors [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS   CURRENT ASSETS: Cash and cash equivalents Marketable securities, at fair value Other current assets   TOTAL CURRENT ASSETS   OTHER ASSETS: Patents, net of accumulated amortization Equity investments Security deposit         Total Other Assets   TOTAL ASSETS   LIABILITIES AND STOCKHOLDERS’ EQUITY: CURRENT LIABILITIES: Accounts payable Accrued payroll Other accrued expenses Total Current Liabilities   LONG TERM LIABILITIES:        Deferred tax liability   TOTAL LIABILITIES   COMMITMENTS AND CONTINGENCIES (Note H)   STOCKHOLDERS’ EQUITY Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at June 30, 2026 and December 31, 2025 Common stock, $0.01 par value; authorized 50,000,000 shares; 22,863,181 and 22,824,009 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS’ EQUITY   TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE OPERATING EXPENSES: Costs of revenue Professional fees and related costs General and administrative Amortization of patents TOTAL OPERATING EXPENSES OPERATING LOSS   OTHER INCOME: Interest and dividend income, net Gain on equity investment Net realized and unrealized gain (loss) on marketable securities Total other income, net   LOSS BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE INCOME TAX PROVISION: Current Deferred tax (benefit) expense, net Total income tax (benefit) expense LOSS BEFORE SHARE OF NET LOSS OF EQUITY METHOD INVESTEE:   SHARE OF NET LOSS OF EQUITY METHOD INVESTEE  NET LOSS Net loss per share Basic Diluted Weighted average common shares outstanding: Basic Diluted Cash dividends declared per share Statement [Table] Statement [Line Items] Beginning balance Beginning balance, shares Dividends and dividend equivalents declared Stock-based compensation Vesting of restricted stock units Beginning balance, shares Value of shares delivered for acquisition of patents Value of shares delivered for acquisition of patents, shares Value of shares delivered to pay withholding taxes Beginning balance, shares Treasury stock purchased and retired Beginning balance, shares Net loss Ending balance Beginning balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash Stock-based compensation Gain on equity investment Share of net loss from equity method investment Deferred tax expense (benefit) Amortization of right of use asset Unrealized loss (gain) on marketable net securities Changes in operating assets and liabilities: Other current assets Accounts payable Operating lease obligations Accrued expenses   NET CASH USED IN  OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES: Sales of marketable securities Purchases of marketable securities Acquisition of patents NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES   CASH FLOWS FROM FINANCING ACTIVITIES: Cash dividends paid Value of shares delivered to fund payment of withholding taxes Repurchases of common stock, inclusive of commissions NET CASH USED IN FINANCING ACTIVITIES: NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for: Interest Income taxes NON-CASH FINANCING ACTIVITIES Accrued dividend rights on restricted stock units, net of forfeitures Shares issued for acquisition of patents Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] BASIS OF PRESENTATION AND NATURE OF BUSINESS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Patents PATENTS Equity [Abstract] STOCKHOLDERS’ EQUITY Earnings Per Share [Abstract] LOSS PER SHARE Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Marketable Securities MARKETABLE SECURITIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Employment Arrangements And Other Agreements EMPLOYMENT ARRANGEMENTS AND OTHER AGREEMENTS LEGAL PROCEEDINGS Equity Method Investments and Joint Ventures [Abstract] EQUITY INVESTMENTS Other Liabilities Disclosure [Abstract] STOCK REPURCHASES Risks and Uncertainties [Abstract] CONCENTRATIONS OF CREDIT RISK DIVIDEND POLICY Use of Estimates and Assumptions Revenue Recognition Equity Investments Income Taxes Segment Reporting Recent Accounting Pronouncements Schedule of revenue disaggregated by source Schedule of patent Schedule of future amortization of intangible assets Schedule of stock option activity Schedule of basic and diluted weighted average common shares outstanding Schedule of marketable securities Schedule of lease cost U.S. Patents owned by the company Expired patents Foreign patents owned by the company Aggregate investment amount Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Total Revenue Deferred tax assets Valuation allowance Deferred tax liability   Gross carrying amount – patents Accumulated amortization – patents   Patents, net 2026 – remaining 2027 2028 2029 2030 Thereafter Total Estimated remaining economic useful of patents Amortization expense Expiration dates of the patents within the Company's M2M/IoT Patent Portfolio Expiration dates within Company's HFT patent portfolio Expiration dates within Company's Smart Home patent portfolio Restricted stock units, outstanding number of units, beginning balance Restricted stock units, weighted average grant date fair value, beginning balance Grants of restricted stock units Grants of restricted stock units, weighted average grant date fair value Vested restricted stock units Vested restricted stock units, weighted average grant date fair value Forfeited restricted stock units Forfeited restricted stock units, weighted average grant date fair value Restricted stock units, Outstanding Number of units, Ending Balance Restricted stock units, weighted average grant date fair value, ending balance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock subject to outstanding awards Common stock available for issuance Restricted stock unit compensation expense Unrecognized restricted stock unit compensation expense Accrued dividend rights on restricted stock unit Weighted-average common shares outstanding – basic Dilutive effect of restricted stock units and stock options Weighted-average common shares outstanding – diluted Restricted stock units excluded from the computation of diluted loss per share because the effect of inclusion would have been anti-dilutive Potentially dilutive shares Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Expected volatility Time to liquidity event Risk-free interest rate Discount for lack of marketability Fair value per share range Schedule of Investments [Table] Schedule of Investments [Line Items] Government securities Fixed income mutual funds Certificates of deposit Corporate bonds and notes Total marketable securities Operating lease cost Short-term lease cost   Total Contingency fee minimum - Patent litigation Contingency fee maximum - Patent litigation Purchase price in Smart Home Smart Home patent acqusition - Contingent First $100 million of Smart Home net proceeds Greater than $100 million of Smart Home net proceeds Cash purchase for HFT Obligation to pay HFT seller additional cash based on achieving certain milestones Contingent common stock issued upon achieving certain milestones First $50 million of HFT net proceeds Greater than $50 million of HFT net proceeds Seller received HFT seller cash based on achieving milestone 2 HFT seller common stock based on achieving milestone 2 Obligated to pay Cox, net proceeds percentage Obligated to pay M2M First $100 million of M2M net proceeds Greater than $100 million of M2M net proceeds Additional consideration payable upon occurrence of certain future events Annual base salary Annual base salary increase Aggregrate investment Issued preferred stock, value Equity investment, carrying value Equity investment corresponding gain Number of shares hold Outstanding securities percentage Stock Repurchase Program, dollar amount, that may be repurchased Number of shares, common stock repurchased Aggregate cost of common stock repurchased Average price per share, common stock repurchased Number of shares authorized to be repurchased Excise tax description Excise tax Value of remaining shares that may be repurchased FDIC insured amount Excess of Insured amount Cash equivalents Dividends, per share - semi-annual Dividends, per share - annual Assets, Current Other Assets Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net Income Tax Expense (Benefit) Shares, Outstanding DividendsAndDividendEquivalentsDeclared ValueOfSharesDeliveredToPayWithholdingTaxes ValueOfSharesDeliveredToPayWithholdingTaxesShares TreasuryStockPurchasedAndRetired TreasuryStockPurchasedAndRetiredShares Share-Based Payment Arrangement, Noncash Expense GainOnEquityInvestment ShareOfNetLossFromEquityMethodInvestment Marketable Security, Unrealized Gain (Loss) Increase (Decrease) in Other Operating Assets and Liabilities, Net Increase (Decrease) in Accounts Payable Cash Provided by (Used in) Operating Activity, Including Discontinued Operation SalesOfMarketableSecurities Payments to Acquire Marketable Securities Payment for Acquisition, Land, Held-for-Use Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Payments of Ordinary Dividends, Common Stock ValueOfSharesDeliveredToFundPaymentOfWithholdingTaxes Payments for Repurchase of Common Stock Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Intangible Asset, Finite-Lived, Accumulated Amortization Intangible Asset, Finite-Lived, after Accumulated Amortization Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value